# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001013762-25-004072
Filing Date
2025-03-28
Accepted
2025-03-28 16:05:24
Documents
104
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | ea0235481-10k_immucell.htm iXBRL | 10-K | 1364643
2 | INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND MICHAEL F. BRIGHAM DATE | ea023548101ex10-10_immucell.htm | EX-10.10 | 17391
3 | AMENDED AND RESTATED INCENTIVE COMPENSATION AND SEVERANCE AGREEMENT BETWEEN THE | ea023548101ex10-11_immucell.htm | EX-10.11 | 38938
4 | INSIDER TRADING POLICY OF THE COMPANY ADOPTED AS OF DECEMBER 11, 2024 | ea023548101ex19_immucell.htm | EX-19 | 62331
5 | CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | ea023548101ex23-1_immucell.htm | EX-23.1 | 2388
6 | CERTIFICATION | ea023548101ex31_immucell.htm | EX-31 | 10530
7 | CERTIFICATION | ea023548101ex32_immucell.htm | EX-32 | 4731
8 | GRAPHIC | image_001.jpg | GRAPHIC | 131262
9 | GRAPHIC | image_002.jpg | GRAPHIC | 127973
10 | GRAPHIC | image_003.jpg | GRAPHIC | 32108
| Complete submission text file | 0001013762-25-004072.txt |  | 8431119

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL SCHEMA FILE | iccc-20241231.xsd | EX-101.SCH | 60606
12 | XBRL CALCULATION FILE | iccc-20241231_cal.xml | EX-101.CAL | 55713
13 | XBRL DEFINITION FILE | iccc-20241231_def.xml | EX-101.DEF | 327765
14 | XBRL LABEL FILE | iccc-20241231_lab.xml | EX-101.LAB | 621923
15 | XBRL PRESENTATION FILE | iccc-20241231_pre.xml | EX-101.PRE | 362766
107 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0235481-10k_immucell_htm.xml | XML | 870172

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12934 | Film No.: 25785916
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)